Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Клинические целевые показатели для интерпретации данных непрерывного мониторинга глюкозы: рекомендации Международного консенсуса по времени в целевом диапазоне
Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy W. Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovč, Francis J. Doyle, Satish K. Garg, George Grunberger, Simon R. Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris P. Kovatchev, Aaron J. Kowalski, Lori M. Laffel, Brian J. Levine, Alexander Yur'evich Mayorov, Chantal Mathieu, Helen Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, KEATON C. STONER, Tatsuiko Urakami, STUART ALAN WEINZIMER, Moshe Phillip
2019-06-08

ATTD consensus recommendationsCGM metricscontinuous glucose monitoringglycemic targetstime in range
Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful utilization of CGM technology in routine clinical practice remains relatively low. This may be due in part to the lack of clear and agreed-upon glycemic targets that both diabetes teams and people with diabetes can work toward. Although unified recommendations for use of key CGM metrics have been established in three separate peer-reviewed articles, formal adoption by diabetes professional organizations and guidance in the practical application of these metrics in clinical practice have been lacking. In February 2019, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address this issue. This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
1
Clear, agreed-upon CGM targets are identified as necessary to improve routine clinical utilization by diabetes teams and people with diabetes.
2
The consensus responds to limited formal adoption and practical guidance from diabetes professional organizations despite previously unified recommendations for key CGM metrics.
3
The international ATTD consensus panel developed recommendations for interpreting and reporting continuous glucose monitoring data in clinical practice.
4
The recommendations address glycemic targets and relevant CGM metrics across diverse diabetes populations.

Continuous glucose monitoring (CGM) data utilization and reporting in people with diabetes

Clinically relevant glycemic targets and practical interpretation of CGM metrics across diverse diabetes populations

Publication Details
Publication Date
2019-06-08
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Tadej Battelino
Thomas Danne
Richard M. Bergenstal
Stephanie A. Amiel
Roy W. Beck
Torben Biester
Emanuele Bosi
Bruce A. Buckingham
William T. Cefalu
Kelly L. Close
Claudio Cobelli
Eyal Dassau
J. Hans DeVries
Kim C. Donaghue
Klemen Dovč
Francis J. Doyle
Satish K. Garg
George Grunberger
Simon R. Heller
Lutz Heinemann
Irl B. Hirsch
Roman Hovorka
Weiping Jia
Olga Kordonouri
Boris P. Kovatchev
Aaron J. Kowalski
Lori M. Laffel
Brian J. Levine
Alexander Yur'evich Mayorov
Chantal Mathieu
Helen Murphy
Revital Nimri
Kirsten Nørgaard
Christopher G. Parkin
Éric Renard
David Rodbard
Banshi Saboo
Desmond Schatz
KEATON C. STONER
Tatsuiko Urakami
STUART ALAN WEINZIMER
Moshe Phillip
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%